WAUKESHA, Wis., May 17, 2016 /PRNewswire/ — The latest innovation from Cardiac Science may not only help save lives but also budget dollars.
Cardiac Science, a global leader in the manufacturing and marketing of automated external defibrillators (AEDs), announced today the creation of Cardiac Science Capital, an innovative solution that allows organizations to finance their entire AED program with no money down, low interest rates, and affordable monthly payments.
“Whether it’s a lack of budget or poor timing, many organizations withhold purchasing AEDs or upgrading their existing AEDs. Unfortunately, a sudden cardiac arrest event does not wait until next year’s budget cycle,” said Al Ford, President of Cardiac Science.
“Organizations need the ability to purchase potentially life saving AEDs without delay, and we believe Cardiac Science Capital provides a much needed solution.”
All Cardiac Science Capital AED packages include a Powerheart® G5 dual-language AED with options for automatic or semi-automatic models, and four years of annual service. Organizations can also add training, accessories, and other services to their package.
Cardiac Science Capital can also help organizations lower their tax bill through the Section 179 Deduction for capital expenditures. In some cases, the tax dollars saved may exceed the monthly payments of an AED package.
“Whether you are starting an AED program or scaling up an existing AED program, Cardiac Science Capital provides the flexibility to spread out payments so you can better manage your cash flow,” added Ford. “Ultimately, we believe this solution will help get more AEDs into the hands of rescuers and, in turn, help save more lives.”
About Cardiac Science
Cardiac Science develops, manufactures, and markets automated external defibrillators (AEDs) and related parts, components and accessories. The company also provides a comprehensive portfolio of training, maintenance, and support services for AED customers. Cardiac Science is headquartered in Waukesha, Wisconsin. The company has operations in North America, Europe and Asia and has an installed base of over 500,000 units in nearly 100 countries worldwide. For information, call 1.800.426.0337 or visit http://www.cardiacscience.com.
For media questions, contact Ric Kositzke at +1.262.953.7624.